The Faris D. Virani Ewing Sarcoma Center
The Faris D. Virani Ewing Sarcoma Center at Texas Children’s Cancer Center (an NCI-designated Comprehensive Cancer Center) was established in 2014 with a little over $1,000 in seed funding from Faris’ personal piggy bank, and is the world’s only comprehensive research center dedicated to Ewing sarcoma. Part of the Solid Tumor Programs at Texas Children’s Cancer Center, the FDV Center is dedicated to advancing the research and treatment of Ewing sarcoma, the second most common bone tumor in children, as well as other sarcomas. A global leader in research and clinical care, the Center also hosts international symposia, an undergraduate internship program, a youth ambassador program, and is home to world’s only round-the-clock access line for anyone affected by Ewing sarcoma. The Center consists of 14 lab team members, and 8 physicians dedicated to seeing Ewing sarcoma patients.
2019 Highlights
– Celebrating the Center’s 5 year anniversary!
– FDV Center Director Dr. Jason Yustein selected as one of 10 experts to lead the Children’s Oncology Group New Agents for Ewing Sarcoma Task Force, which published a landmark report in April.
– The creation of a Monthly Sarcoma Research Conference for faculty and trainees from across the Texas Medical Center; led by Dr. Yustein and Dr. Lisa Wang, the conference has already significantly enhanced studies in Ewing sarcoma and galvanized interest in pediatric sarcomas, while also providing a valuable educational opportunity as a forum for feedback and discussion.
15 lab tours
for students, families, volunteers, and other groups
8 collaborations
with other institutions and pharmaceutical companies
14 new patients
making the FDV Center one of the largest centers treating Ewing sarcoma patients